As of Jul 31
| +0.02 / +0.24%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 13.50. The median estimate represents a +76.47% increase from the last price of 8.50.
The current consensus among 7 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.